An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al

Arthritis Rheumatol. 2024 Feb;76(2):315-316. doi: 10.1002/art.42689. Epub 2023 Oct 30.

Authors

Mia Rodziewicz¹, Sarah Dyball¹, Sheilla Achieng¹, Silke R Brix², Ben Parker², Ian N Bruce³

Affiliations

¹ University of Manchester, Manchester, UK.
² Manchester Academic Health Science Centre, Manchester, UK.
³ University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

PMID: 37653671
DOI: 10.1002/art.42689

No abstract available

Publication types

Letter
Comment

MeSH terms

Biological Products* / therapeutic use
Humans
Lupus Erythematosus, Systemic* / drug therapy

Substances

Biological Products

Grants and funding

MR/N025989/1/MRC_/Medical Research Council/United Kingdom